Ramón Cacabelos, M.D., Ph.D., D.M.Sci.
“Service to others dignifies the human being”
Dr. Ramón Cacabelos is President of the EuroEspes Group and Chair of Genomic Medicine, formed by EuroEspes Medicine, the company managing the EuroEspes Medical Center, a world benchmark in Genomic Medicine and diseases of the Nervous System; EuroEspes Biotechnology, the industrial branch of the Group, devoted to the research and manufacture of nutraceutical bioproducts and vaccines; and EuroEspes Publishing, a company committed to scientific dissemination, medical education and genomic medicine.
Dr. Ramón Cacabelos was born in Cambados, graduated in Medicine and Surgery at the University of Oviedo and obtained his PhD in Medicine and Surgery at the University of Santiago de Compostela. He then spent a decade in Japan, where he obtained a PhD in Medical Science, Internal Medicine and Psychiatry, specializing in Psychiatry at the Faculty of Medicine of Osaka University. After returning to Spain, he worked as a Professor at the Department of Psychiatry of the Faculty of Medicine at the University of Santiago de Compostela, Tenure Professor of Human Physiology at the Complutense University Medical School in Madrid, and Chair of Genomic Medicine at the Camilo José Cela University in Madrid, where he was also Vice-Chancellor for Research and Science. Since 1995 he has been the Founding Chairman and Director-General of the EuroEspes Biomedical Research Center, Institute of Medical Sciences and Genomic Medicine in Corunna. He also holds the Presidency of the Spanish Society of Genomic Medicine and the World Association of Genomic Medicine.
Ramón Cacabelos is one of the most internationally renowned Spanish scientists in the field of disorders of the central nervous system, aging and dementia, and a pioneer in Genomic Medicine and Pharmacogenomics. During his professional career he has published over 1,500 international scientific contributions, over 20 books, and he is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics. His extensive experience and scientific prestige have placed him on over 50 international scientific committees for the evaluation of projects, and also as the medical and scientific advisor of several governmental bodies in various countries. He is also Editor-in Chief of the domestic and international editions of Gen-T, the EuroEspes Journal, of 5 volumes of Research Reports, 2 volumes of CJC University Health Science Reports, and of several international scientific journals, among which the Journal of Genomic Medicine and Pharmacogenomics and the Journal of Exploratory Research in Pharmacology, both published in the United States, are of particular note. As an inventor, he holds 10 patents, the two most recent being the EB-101 vaccine against Alzheimer’s disease, registered at the United States Patent Office, and Atremorine, a bioproduct registered at the European Patent Office, for the prevention and treatment of Parkinson’s disease.
From his forays into the world of literature and essays, works such as “Japón: Lecciones de una Cultura en Salud Pública y Bienestar Social” [Japan: Lessons from a Culture of Public Health and Social Well-Being] (1996), “Pensamientos de Outsider” [Thoughts of an Outsider] (2005), “El Legado de Garkok” [Garkok’s Legacy] (2006), and “Papeles” [Papers] (2015) have seen the light. An intellectual committed to the society in which he lives, Dr. Cacabelos is a prolific contributor to many domestic and foreign newspapers and journals, with over 200 popular articles covering subjects such as politics, the problems afflicting our society, and always with a critical stance in order to further progress and to promote people’s well-being.